Extension of preclinical research collaboration agreement with a top-10 large pharma company

Posted on Jan 18, 2018

Oslo (Norway), 18 January 2018 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announced that they are extending the preclinical research collaboration with an undisclosed top-10 pharma company, initiated in September 2015. The extended evaluation period spans over 6 months, until the end of June 2018, and may be further extended. The […]

PCI Biotech to present at Biotech Showcase 2018

Posted on Jan 8, 2018

Oslo, Norway, January 8, 2017 – PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present at Biotech Showcase 2018 being held January 8-10, 2018 at the Hilton San Francisco Union Square, California, US. On Tuesday, January 9, 2019 at 04:00pm (PST), Dr. Per Walday, […]